Bromopyridazinedione-mediated protein and peptide bioconjugation.
about
Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineeringA rapid, site-selective and efficient route to the dual modification of DARPins.A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy.Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation.Chemical Protein Modification through Cysteine.A novel approach to the site-selective dual labelling of a protein via chemoselective cysteine modification.Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic.Dual modification of biomolecules.A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy.The Cysteine S-Alkylation Reaction as a Synthetic Method to Covalently Modify Peptide Sequences.Site-Selective Disulfide Modification of Proteins: Expanding Diversity beyond the Proteome.Next-generation disulfide stapling: reduction and functional re-bridging all in one.A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones.Reversible protein affinity-labelling using bromomaleimide-based reagents.A novel synthetic chemistry approach to linkage-specific ubiquitin conjugation.A platform for efficient, thiol-stable conjugation to albumin's native single accessible cysteine.Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range.Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones.A mild TCEP-based para-azidobenzyl cleavage strategy to transform reversible cysteine thiol labelling reagents into irreversible conjugates.Forming next-generation antibody-nanoparticle conjugates through the oriented installation of non-engineered antibody fragments.
P2860
Q33587970-ABDD8DAF-98CF-481C-B762-0EB2E9768AF6Q33879313-23627582-F4AF-4BDA-B99E-672351E3977DQ36097775-6DFB8017-DA7A-46B2-B439-1A2145B5F02BQ38497871-6FF6D448-4970-49F0-B6A4-12CC6EE62452Q38704033-C92A06AA-F75A-4D01-A8D9-4B66420CA36EQ38728279-84205498-21F8-48D7-8DAA-6C3B7AADFAE8Q38837846-BFD2A9BB-7449-4D4C-926C-9F0CDC6FE981Q38859640-8CA166D0-D210-46FE-A729-BD61F8EC8440Q38892876-16FA6DD7-DB5A-41D8-A7A2-7B34E2E0AB2EQ38931075-63DE63AE-FAD0-4DBC-8B60-79DB34109576Q38990118-C23BCA5D-F0A3-41F3-8C40-B3E3978CAF87Q41773582-997DD0EC-446D-4939-931A-35661479B8E2Q42095021-3EE05EA4-53C3-4F9B-8472-5EADE92A7880Q42585959-DCD72B42-1047-411B-A6C9-F6673298006DQ42699301-0DA83D33-A97C-4F87-9806-B4A05C63DC13Q43154296-24F89688-5194-480C-88DB-201187EF7B2CQ47272955-70662391-42EC-4915-ADDA-78EE8858E9E6Q48100351-76F726BD-24D0-44DF-B9A4-AB83DE2F5A22Q51033890-0B18D1A3-CCE2-4395-9B50-44C1A631A125Q52599608-B212BA4B-7511-46EF-A301-423365A6FB95
P2860
Bromopyridazinedione-mediated protein and peptide bioconjugation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@en
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@nl
type
label
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@en
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@nl
prefLabel
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@en
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@nl
P2093
P2860
P356
P1476
Bromopyridazinedione-mediated protein and peptide bioconjugation.
@en
P2093
Danai Papaioannou
Felix F Schumacher
Gabriel Waksman
James R Baker
Mark E B Smith
Stephen Caddick
Vijay Chudasama
P2860
P304
P356
10.1039/C1CC12807H
P407
P577
2011-07-07T00:00:00Z